Small Cap Wrap: Month: October 2016

AIM Breakfast - Archive

31st October 2016

FreeAgent—FT reports the provider of accounting software to small businesses is intending to announce its intention to float today looking to raise £8m

Ascot Lloyd –City A.M. reports the wealth manager has postponed its IPO after failing to find sufficient investor support

Filta— AIM Schedule One update  from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets 4 November listing. Seeking £4.3m new equity plus £1.9m shareholder sale

Read More...

28th October 2016

Misys—‘Despite encouraging institutional support Misys Group Limited has decided not to proceed with its potential initial public offering at the current time due to market conditions.‘

BB Healthcare Trust targeting a £200m issue on the main market. BB Healthcare will be a high conviction, long-only investment trust invested in listed or quoted global healthcare equities.

Filta— AIM Schedule One from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets early November listing. Capital raising plans as yet undisclosed

Read More...

27th October 2016

Misys—’Despite encouraging institutional support Misys Group Limited has decided not to proceed with its potential initial public offering at the current time due to market conditions.‘

BB Healthcare Trust targeting a £200m issue on the main market. BB Healthcare will be a high conviction, long-only investment trust invested in listed or quoted global healthcare equities.

Filta— AIM Schedule One from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets early November listing. Capital raising plans as yet undisclosed

Read More...

26th October 2016

Golden Rock Global— Prospectus published (Standard List). Issuing 3.5m shares at 10p. Seeking fintech acquisitions. Admission due 31 October

Filta— Schedule One from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets early November listing. Capital raising plans as yet undisclosed

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

Read More...

25th October 2016

Filta— Schedule One from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets early November listing. Capital raising plans as yet undisclosed

 Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

Read More...

21st October 2016

 Petards on the right tracks

Sareum gets its patents

RM2 gets stacking

 

Applied Graphene Materials (LON:AGM 173.00p/£37.39m)

Applied Graphene Materials, the producer of specialty graphene materials, announced its full year results for the year ended 31 July 2016. Operational highlights showed first production order received from Century Composites, accelerated product development programme with James Briggs with an expectation of product launch in early 2017 and a new collaboration project with Sherwin-Williams Protective & Marine Coatings. Independent test data showing significant benefits of including the Group’s graphene nanoplatelets in coatings. The financial overview showed total revenues of £0.3m (2015: £0.1m), EBITDA Loss of £4.2m (2015: loss of £3.9m) and a Loss before tax of £4.5m (2015: loss of £4.0m). Cash at bank was £7.7m (2015: £4.7m).

Cambridge Cognition (LON:COG 71.00p/£14.52m)*

The neuroscience Company, Cambridge Cognition Holdings, which develops and markets near patient technologies to facilitate the development of treatments for neurological disorders, announced a series of new contracts worth over £0.25m to assess, through CANTAB Connect, the abuse potential of investigational drugs in a new market application for the Company. Cambridge Cognition has become the leading provider of Human Abuse Liability (HAL) assessment technology, helping the Company’s drug development partners to achieve multiple FDA approved abuse deterrent labels. To date the Company has signed 35 HAL contracts following the launch of the CANTAB Connect Abuse Liability product (vs. 8 before 2014), with revenues totalling in excess of £3m (vs. £0.6m before 2014) in a market which is expected to continue to grow.

Cohort (LON:CHRT 347.75p/£145.41m)

Cohort, the independent technology group, announced that its subsidiary MASS has been awarded a nine-year extension to its managed IT service contract for the Sentry Whole Life Support Programme (WLSP) at RAF Waddington. Valued at around £12m, the scope of the support contract now includes replacement of the Maintenance, Repair and Overhaul software and adds an Enterprise Performance Management solution. The team is led by Northrop Grumman with MASS, AAR Corp and Cobham Aviation Services partnering together to support and maintain the availability of the UK’s fleet of Airborne Warning and Control System (AWACS) aircraft.  Northrop Grumman commented that this nine-year extension recognises MASS’s agile response to ever-changing needs and the provision of a first-rate, value for money service.

InnovaDerma (LON:IDP 122.5p/£12.5m)*

InnovaDerma, a UK developer of ‘at-home’ and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, provided an update on trading ahead of its Final Results for the twelve-month period ended 30 June 2016. The Board announced that it expects revenue and profits for the full year to 30 June 2016 will be significantly higher than the previous year, driven by underlying organic growth across its product range and the contribution of the Skinny Tan business, which was acquired in May 2015. The Group expects to report revenues of approximately AUD8.3m (£4.2m) representing a significant increase of more than 800 percent compared to the previous year FY 2015: AUD1.05m (£0.525m). It expects to announce a maiden net profit as a result of the strong top line growth. The Group has maintained a robust financial position with little external debt and a strong cash position. InnovaDerma significantly expanded its international distribution and retail network and this has been a key driver to its growth and strong financial performance. As at 30 June 2016, the Company has in excess of 2,500 retail points (FY2015: 250) in seven countries.

Kibo Mining (LON:KIBO 7.33p/£26.76m)

Kibo Mining, the Tanzania focused mineral exploration and development Company, announced that it has reached agreement with SEPCO III on the total direct development cost related to the MCPP (Mbeya Coal to Power Project). It was agreed that the direct development cost incurred on the MCPP over the past four years will be considered for determining the final development cost refund amount. After considering all information provided in this regard, the final amount is $10.9m, which was accepted by both parties as a fair reflection of the MCPP development cost over the past four years. Based on this, the total amount refundable to Kibo constitutes an amount of $5.5m, i.e. 50 percent of the total development cost as per the terms of the Agreement between SEPCO III and the Company, announced on the 25 August 2016. As Kibo has already received an advance of $1.8m, the total outstanding amount payable to Kibo will be £3.7m.

Milestone Group (LON:MSG 1.30p/£10.02m)*

Milestone, the provider of digital media and technology solutions, announced that it has agreed to issue 92,333,332 new ordinary shares of 0.1 pence per share in the Company, subject to admission to AIM, raising £1.385m before expenses, at a price of 1.5 pence per share. The proceeds of the Placing will be used for marketing of the newly launched Alchemy e-media platform, recruiting key staff, and additional development of the Passion Project platform.

Petards Group (LON:PEG 18.50p/£6.43m)*

Petards, the software developer of advanced security and surveillance systems, announced that it has been awarded a contract to supply Great Western Railway with Petards eyeTrain systems. The new contract, which is worth approximately £6m, is for the design, development, supply and installation of eyeTrain systems to be fitted to Class 165 and 166 Diesel Multiple Units trains.  The developed systems add substantial new software driven functionality to Petards’ existing eyeTrain solutions. Engineering development is already underway and will make a contribution to 2016 revenues. This is expected to be completed by the third quarter of 2017 when deliveries of the integrated systems will commence with scheduled completion by the end of 2018.

ProMetic Life Sciences (TSX:PLI CAD3.21/CAD1,997.47m)*

ProMetic Life Sciences announced that its Phase 2 clinical trial in patients with metabolic syndrome and type 2 diabetes has been completed and has met its primary and secondary endpoints. In addition to safety and tolerability, the study was designed to evaluate the effect of PBI-4050 on metabolic syndrome parameters as well as on pro-inflammatory/fibrotic and diabetic biomarkers in blood and urine. The pharmacological activity of PBI-4050 was confirmed through the clinically significant reduction in HbA1c between screening and Week 12. For instance, the 15 patients with a screening HbA1c ≥ 7.5 experienced a mean decrease of – 0.75% (p = 0.0004) while the 9 patients with a screening HbA1c ≥ 8.0% experienced a mean decrease of – 0.9% (p = 0.007). The 10 patients who participated in the study’s 12 week extension had a mean HbA1c of 7.7 at screening and experienced a reduction of – 0.8% at week 12: this reduction was maintained at week 24.

RM2 (LON:RM2 25.92p/£103.92m)

RM2, the sustainable composite pallet innovator, announced that it has received a commitment from a global leader in temperature-controlled warehousing and logistics to the food industry, for the deployment of RM2 pallets and management of the Company’s pallet pool.  The deployment of pallets will start immediately and based upon the success of the initial locations, the business is projected to encompass the Company’s North American network. It is anticipated that the agreement will require over 200,000 pallets.

 Sareum Holdings (LON:SAR 1.1p/£29.15m)*

Sareum, the specialist cancer drug discovery and development business, announced that the Japan and Singapore Patent Offices have issued notifications that patents will be granted for inventions associated with Sareum’s Aurora+FLT3 kinase inhibitor programme. These patents* describe compounds that inhibit the activity of Aurora and FLT3 kinase enzymes and the medical use of these compounds, particularly in the treatment of cancer. The granting of this patent in Japan means that Sareum will now have approved patent protection in all major territories for its Aurora+FLT3 kinase inhibitor programme. The Company announced that similar patents were to be granted in the USA and Europe in September 2015 and in China in August 2016.

Vianet Group (LON:VNET 100.50p/£28.11m)

Vianet Group, the leading provider of real time monitoring systems, data management services and business intelligence for the leisure and vending sectors, provided the following trading update ahead of the Group’s results for the half year ended 30 September 2016, which are scheduled for release on Tuesday, 6 December 2016.Trading for the Group’s continuing businesses for the first half of the current financial year was ahead of the same period last year, achieving good growth in line with the Board’s expectations. Against that background, the Board intends to declare a maintained interim dividend of 1.7p per share. The Group’s UK core beer flow monitoring operations, including iDraught, has continued to strengthen its market position and maintained its contribution, and encouragingly there are signs that the rate of pub closures in the sector has slowed down. Vending Telemetry has continued to extend its penetration of the European market which has helped deliver first half growth, with good ongoing prospects.

Price charts provided by : http://www.investegate.co.uk/ and http://www.isdx.com/

24th October 2016

Filta— Schedule One from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets early November listing. Capital raising plans as yet undisclosed

TI Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

Read More...

21st October 2016

Filta— Schedule One from  the provider of a number of services to national and independent commercial kitchen operators and owners.   Targets early November listing. Capital raising plans as yet undisclosed

TI Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

Read More...

20th October 2016

Misys— Press reports that the IPO valuation is to be cut by £1bn against an expected £5bn

TI Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

 

Read More...

19th October 2016

Misys— Press reports that the IPO valuation is to be cut by £1bn against an expected £5bn

TI Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

 

Read More...

18th September 2016

Misys— Press reports that the IPO valuation is to be cut by £1bn against an expected £5bn

TI Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

Read More...

17th September 2016

TI Fluid Systems– has decided not to proceed with its proposed initial public offering at the current time due to market conditions

Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

 

Read More...

14th October 2016

Biffa— The waste disposal company’s IPO is also now in doubt with the valuation coming under scrutiny according to the press

TI Fluid Systems– has decided not to proceed with its proposed initial public offering at the current time due to market conditions

Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

 

Read More...

13th October 2016

Biffa— The waste disposal company’s IPO is also now in doubt with the valuation coming under scrutiny according to the press

TI Fluid Systems– has decided not to proceed with its proposed initial public offering at the current time due to market conditions

Van Elle—The geotechnical contractor to the UK construction market is hoping to come to AIM later this month

Ascot Lloyd— The UK IFA is also hoping to join AIM later this month. Ascot Lloyd’s strategy is to grow through a combination of organic growth and further targeted acquisitions.

 

Read More...

12th October 2016

Pure Gym—The kitchen got a little too hot for Pure Gym which has  recently pulled its expected listing

Krispy Kreme UK—is understood to have abandoned its planned £200m London flotation in favour of a sale to its US parent

Biffa— Intention to float announcement states that up to £270m  is to be raised to pay down debt and historic landfill tax liability

Misys— Intention to float issued last week. Expected early November. Targeting £500m primary for deleverage and partial shareholder sale

 

Read More...

5th October 2016

Petards on the right tracks

Sareum gets its patents

RM2 gets stacking

Ace Liberty & Stone Plc (LON:ALSP 4p/£39.3m)*

alsp

Ace Liberty and Stone, the active property investment Company, capitalising on commercial property investment opportunities across the UK, announced its Final Results for the year ended 30 April 2016. Highlights showed the Group’s property holdings have grown 23 percent during the year from £23.96m to £29.49m. Total equity attributable to owners has increased by 45 percent in the year to £17.94m (2015: £12.41m). Consolidated Revenue for the year increased 70 percent to £2.04m (2015: £1.2m). Profit before tax decreased to £0.6m (2015: £1.06m) as a result of a reduced portfolio valuation as  at 30th April 2016. Profit-yielding sales of properties including the final holding in Telephone House, Sheffield for £4m  and Princegate House, Doncaster (excluding car park) for £0.85m. The sale of Hume House has been agreed at £3.55m for completion in December 2016. The Company also announced a further addition to the Company’s portfolio with the purchase of 1-5 Upper Market Square, Hanley. The contracts were exchanged on 8 August 2016 by Ace (Hanley) Limited, a 100 percent subsidiary of the Company, for the sum of £9m, with completion on 8 November 2016. The property is located in a prime position in Hanley, which is the primary commercial centre of Stoke-on-Trent. It is comprised of two retail units arranged over basement, ground and three upper floors, totalling 59,358 square feet. 74 percent of the letting income comes from Boots Limited, with 24 years unexpired and remaining income from National Westminster Bank for 12 years.

Cambridge Cognition (LON:COG 83.00p/£17.27m)*

cog

The neuroscience Company which develops and markets near patient technologies to facilitate early intervention and development of treatments for neurological disorders, announced the signing of two major contracts using the Company’s CANTAB Connect technology. The contracts totalling US$3.67m (£2.82m) are with US biopharmaceutical companies for late stage clinical trials and will contribute US$1.07m(£0.82m) to reported revenue in the second half of 2016. The award of the contracts was expected and so the outlook for the current year remains unchanged.

Conroy Gold and Natural Resources (LON:CGNR 26.5p/£3.05m)*

cgnr

Conroy Gold and Natural Resources, the gold exploration and development Company focused on Ireland and Finland, announced the latest results from its drilling programme on the Clontibret gold deposit at the southwestern part of the Company’s Clay Lake – Clontibret gold property. High grades and wide intersections included 0.50m at 25.85 g/t gold in one of the already known gold zones and 5.75m grading 5.04 g/t gold in one of the newly discovered gold zones. Five new gold zones (lodes) were discovered during the latest drilling. Gold intersections were also made in four known gold zones in the area, confirming continuity of these lode zones. The deposit remains open to depth and in all directions. The drilling focused on upgrading, at this stage to a depth of 200m, an area where previous drilling had indicated the potential for significant widths and gold grades.

 Fitbug Holdings (LON:FITB 0.24p/£2.93m)*

fitb

 Fitbug Holdings , the provider of corporate wellness solutions and services, announced its Interim Results for the six months ended 30 June 2016. Implementation of turnaround strategy away from retail to Corporate Wellness has been underway, total sales of £0.73m (2015: £0.99m), with B2B sales of £0.56m (2015: £0.37m) leading to gross profit of £0.41m (2015: £0.53m) and a loss before tax £(1.6m) (2015: £(3.22m)). Good progress has been made on Corporate Wellness offering made with three strategic partners and also there has been a significant reduction in permanent cost base and engagement of outsourced service providers for development of platform and ancillary services (IT, logistics, finance admin).

 ITM Power (LON:ITM 20.59p/£44.55m)

itm

ITM Power, the energy storage and clean fuel Company, announced the completion of the 700 bar upgrade to the M1 Rotherham hydrogen refuelling station (HRS) funded by The UK Government, Office of Low Emission Vehicles (OLEV). On 28 March 2015, the Company announced that it had been awarded a total of £2.89m by the HRS infrastructure Grants Scheme, run by OLEV. The award was to build two new HRS in London, sited with strategic partners and for the upgrading of four existing ITM Power refuelling stations including the M1 Rotherham HRS. The HRS, originally funded by Innovate UK, is located at the Hydrogen Mini Grid at the Advanced Manufacturing Park in Rotherham just of J33 of the M1, close to the junction with the M18. The HRS is an important strategic part of the UK hydrogen infrastructure enabling vehicles from London to access the North of England. Using the existing electrolyser to generate hydrogen from an on-site wind turbine, the original 350 bar dispenser has been upgraded to a new BOC/Linde system capable of dispensing hydrogen at both 700 and 350 bar.  The higher pressure of 700 bar satisfies the requirements of a broader range of vehicles and enables fuel cell electric vehicles such at the Toyota Mirai and Hyundai ix35 to achieve their full driving range of over 300 miles.  New and existing customers will also benefit from automated payment facilities.

 MediaZest (LON:MDZ 0.15p/£1.89m)*

mdz

MediaZest, the creative digital audio visual Company, updated shareholders with more detail on recent business wins. The Group confirmed that the new Rockar project noted in the results announcement of 12 August 2016 relates to audio visual design, build and installation services at their new showroom at Westfield Stratford in collaboration with Jaguar Land Rover. This follows previous work with Rockar in conjunction with Hyundai, which began in 2014, with a first physical site at Bluewater shopping centre in Kent followed by a second Rockar-branded store in Westfield Stratford – a project for which the Company also completed the audio visual design, build and installation services. Separate to this, the Company announced over £250,000 of new business wins secured since 12 August.

 Netcall (LON:NET 54.35p/£40.44m)

net

Netcall, a leading customer engagement software provider, announced that it has secured a minimum £1.5m contract with a FTSE 250 Company. The Company is an existing customer of Netcall’s business process automation product. The new five year contract is for the delivery and use of Netcall’s Liberty omni-channel Contact Centre, Unified Communications, Workforce Optimisation and Customer Experience Manager solutions. Each module will be delivered using the Liberty Software as a Service (SaaS) model. Netcall’s SaaS based Liberty solutions have been selected by the customer as part of a major transformation project for their existing contact centre and customer support infrastructure. They will enable the customer to improve internal operations, performance and productivity, bringing together multiple service lines into a single virtual customer engagement platform, while creating a better customer experience and driving competitive differentiation. The customer also recently signed a significant extension agreement for Netcall’s business process automation product which will continue to run as a premise-based solution. This demonstrates the Liberty platform’s strength as a blended platform, catering for both the rapidly growing SaaS market while continuing to provide sophisticated solutions for customers requiring a premise-based installation.

Physiomics (LON:PYC 0.024p/£1.45m)*

pyc

The Company announced that it has completed a placing, conditional only on Admission, to raise £555,000 at a price of 0.025p per share. There was strong investor interest in the new Company management and in the clinical version of the Company’s Virtual Tumour technology.  Based on investor discussions, they decided not to proceed with the acquisition of BioMoti Limited which was announced by previous management on 31st March 2016.  Shareholders were more supportive of management focusing 100 percent of their efforts on growing the revenues and creating a path to profitability in the core modelling and simulation business at this point. There may be opportunities in the future to engage with BioMoti and other companies with interesting pipelines that Physiomics can optimise, and the Company remains committed to exploring these options.  In the meantime, the proceeds of the placing will be used to conduct and accelerate business development activities related to the Company’s core modelling and simulation business, in particular the clinical version of its Virtual Tumour technology which enables predictions to be made of the outcome of human trials based on pre-clinical and other data.

 Proxama (LON:PROX 1.08p/£18.92m)

prox

Proxama, the leading mobile proximity marketing expert, announced that GLACÉAU smartwater, owned by Coca Cola, is the latest brand to utilise their proximity products and services. GLACÉAU smartwater has commissioned an engaging new out of home campaign that uses Proxama’s beacon technology to share tips from influential Londoners, with members of the public. Launched on 12th September, the outdoor campaign, alerts users in the nearby proximity and will be live until the end of September. From the tastiest brunch in Chelsea to the trendiest pedicure in Hoxton, the GLACÉAU smartwater campaign aims to distil the very best bits of London into ‘on-the-go’ recommendations for busy Londoners.  The adverts, located in areas within Chelsea and Hoxton, will alert consumers to check out top tips from London based influencers, including blogger Reem Kanj and stylist Roxie Nafousi. Smartphone users with Mapway’s Bus London Android app installed will receive a push notification encouraging them to click and discover top recommendations in the area.

 Sareum (LON:SAR 1.16p/£30.80m)*

sar

Sareum Holdings, the specialist cancer drug discovery and development Company,  announced that its co-investment partner, the CRT Pioneer Fund, has licensed exclusive and worldwide rights for the Chk1 inhibitor cancer drug candidate CCT245737 (to be renamed PNT737) to ProNAi Therapeutics, Inc. (NASDAQ: DNAI). Under the terms of the agreement, an immediate upfront payment of US$7.0m is due to the co-investment partners and an additional fee of up to US$2.0m will be payable upon the successful transfer of the two ongoing Phase 1 clinical trials to ProNAi.  Additional payments in the aggregate amount of up to US$319.5m may become payable upon achievement of certain development, regulatory and commercial milestones. ProNAi will also owe high single to low double digit royalties on the net sales of any product successfully developed. Under Sareum’s agreements with Cancer Research Technology and the CRT Pioneer Fund, Sareum is entitled to 27.5 percent of these payments. Therefore, Sareum will receive (i) US$1.9m as an upfront payment, (ii) potential future milestone payments of up to US$88.4m, some of which are expected to be paid within the next twelve months upon certain development milestones being met and (iii) its share of any sales royalties.  Furthermore, the unspent balance, estimated at c£300,000, of the financial commitment to the trial funding of £797,500 made by Sareum in December 2015 will be returned to the Company.

 Venn Life Sciences (LON:VENN 23.54p/£14.77m)*

venn

Venn Life Sciences, a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announced its unaudited interim results for the six months ended 30 June 2016. Financial Highlights showed revenue of €9.06m (H1 2015: €4.25m), EBITDA profit of €0.40m (H1 2015: profit of €0.09m) and an Operating Loss of €0.033m (H1 2015: loss of €0.079m). Cash and cash equivalents of €1.75m at 30th June 2016 (€1.10m at 30th June 2015) and Cash and cash equivalents of €2.10m at 23rd September 2016. Operational Highlights showed progress on Kinesis integration and initial cross sales achieved. Continued progress on systems infrastructure with resultant improvements in operating margins, with successful achievement of key project milestones leading to strong client endorsements and repeat business. The Company also strengthened the board with the appointment of Allan Wood as non-Executive Chairman and Mary Sheahan as non-Executive Director, continued positive progress on new business with €2.8m contract and preferred vendorship with big Pharma announced in August. Lastly, the Company has entered into a process to sell its innovation division, Innovenn. This sale will represent the culmination of several months of effort to re-position Innovenn in such a way that will bring better clarity to the performance of the core business, and realise value from an investment in Innovenn.  The Company also  announced that its wholly owned subsidiary, Venn Life Sciences Limited, has entered into a conditional agreement under which it and Lynchwood Nominees Limited, as custodian for the Helium Rising Stars Fund, would sell the entire issued share capital of Innovenn UK Limited for a total consideration of up to £4.74m.

Price charts provided by : http://www.investegate.co.uk/ and http://www.isdx.com/

05 October 2016

Premier Asset Management— the retail asset management group has raised £63.7m at  132p and is due to join AIM on 7 October.

ConvaTec — The medical products manufacturer is expected to announce a planned London IPO according to City A.M. Other reports suggest a valuation of circa £5 billion.

O2—Press reports that Telefonica will bring O2 to the LSE this year with a large retail offer. This has not yet been confirmed

Biffa— Intention to float announcement states that up to £270m  is to be raised to pay down debt and historic landfill tax liability.

 

Read More...

4th October 2016

Premier Asset Management— the retail asset management group has raised £63.7m at  132p and is due to join AIM on 7 October.

ConvaTec — The medical products manufacturer is expected to announce a planned London IPO according to City A.M. Other reports suggest a valuation of circa £5 billion.

O2—Press reports that Telefonica will bring O2 to the LSE this year with a large retail offer. This has not yet been confirmed

Biffa— Intention to float announcement states that up to £270m  is to be raised to pay down debt and historic landfill tax liability.

 

Read More...

3rd October 2016

ConvaTec — The medical products manufacturer is expected to announce a planned London IPO according to City A.M. Other reports suggest a valuation of circa £5 billion.

Mila Resources—The natural resources focused company has published a prospectus  in relation to a main market listing and £1.1m raise at 5p.

Krispy Kreme UK—Press reports that Alcuin Capital Partners, the owner of  the doughnut chain is seeking a London float this year

Biffa— Intention to float announcement states that up to £270m  is to be raised to pay down debt and historic landfill tax liability.

 

Read More...